Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL252026 | 0.84 | HPGD (0.79) | BLMPOLBHPGDALDH1A1MEN1 | |
| SCHEMBL7129676 | 0.84 | HPGD (0.79) | BLMPOLBHPGDALDH1A1MEN1 | |
| SCHEMBL7848463 | 0.84 | BLM (0.73) | BLMPOLBHPGDALDH1A1MEN1 | |
| SCHEMBL12582715 | 0.83 | BLM (0.71) | BLMPOLBHPGDALDH1A1MEN1 | |
| SCHEMBL7838912 | 0.83 | BLM (0.71) | BLMPOLBHPGDALDH1A1KMT2A | |
| SCHEMBL16098566 | 0.83 | BLM (0.71) | BLMPOLBHPGDALDH1A1KMT2A | |
| SCHEMBL7838280 | 0.83 | BLM (0.71) | BLMPOLBMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL1597472 | 0.82 | HPGD (0.76) | BLMPOLBHPGDALDH1A1MEN1 | |
| SCHEMBL4293002 | 0.82 | BLM (0.70) | BLMHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL24549804 | 0.82 | BLM (0.70) | BLMPOLBHPGDALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676470-A2 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2026-01-14 | — | — | EP | claimed |
| WO-2024187191-A2 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2024-09-12 | — | — | WO | claimed |
| US-20240299484-A1 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP | 2024-09-12 | — | — | US | claimed |
| US-20240033269-A1 | PPARAXANTHINE-BASED COMPOSITIONS FOR INHIBITING INFLAMMATION, IMPROVING JOINT HEALTH, AND ENHANCING IMMUNE FUNCTION | PX ING, LLC | 2024-02-01 | — | — | US | claimed |
| EP-3237903-B1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RES & ENG CO (US) | 2020-02-26 | — | — | EP | claimed |
| EP-3237903-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | Exxonmobil Research And Engineering Company (US) | 2017-11-01 | — | — | EP | claimed |
| EP-3237904-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | Exxonmobil Research And Engineering Company (US) | 2017-11-01 | — | — | EP | claimed |
| US-20160187314-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | US | claimed |
| WO-2016106214-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | WO | claimed |
| WO-2016106211-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | WO | claimed |
| US-20160187315-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | US | claimed |
| US-20260097224-A1 | METHODS FOR MODULATING NEUROPLASTICITY | AMPA INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4676470-A2 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250334522-A1 | FEMTO-LEVEL DETECTION OF ANALYTE USING SURFACE ENHANCED RAMAN SCATTERING (SERS) SUBSTRATE AND PROCESS THEREOF | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-10-30 | — | — | US | disclosed |
| US-20240299484-A1 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP | 2024-09-12 | — | — | US | disclosed |
| WO-2010098495-A1 | IMIDAZOLYLPYRAZINE DERIVATIVES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010098487-A1 | NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS BETA AMYLOID PRODUCTION INHIBITORS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-09-02 | — | — | WO | disclosed |
| US-20100130537-A1 | CINNAMIDE COMPOUNDS FOR DEMENTIA | EISAI R&D MANAGEMENT CO., LTD (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-2181992-A1 | POLYCYCLIC COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2010-05-05 | — | — | EP | disclosed |
| US-20090062529-A1 | MULTI-CYCLIC COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD., (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130537-A1 | CINNAMIDE COMPOUNDS FOR DEMENTIA | GRIN1, GRIN2A, GRIN3A | BLM 4841/4885POLB 4003/4885HPGD 2992/4885 |
| US-20260097224-A1 | METHODS FOR MODULATING NEUROPLASTICITY | GABRE, BDNF, GRIN2A | BLM 4846/4885POLB 2379/4885HPGD 1638/4885 |
| US-20090062529-A1 | MULTI-CYCLIC COMPOUNDS | APP, BACE1, PSEN1 | BLM 1903/4885POLB 3970/4885HPGD 1319/4885 |
| US-20240299484-A1 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | CPT1B, PYGM, LPL | BLM 4019/4885POLB 2869/4885HPGD 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.